Shu-Jyuan Chang
Overview
Explore the profile of Shu-Jyuan Chang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
186
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kuo K, Chang S, Tsai C, Huang Y, Kwan A, Chai C
Adv Med Sci
. 2025 Jan;
70(1):103-108.
PMID: 39855471
Purpose: Patients with meningiomas mostly present good outcomes and optimal prognosis, but different grades of tumors have very different symptoms and recurrence rates. Therefore, effective diagnosis is crucial for early...
2.
Wu Y, Chang S, Huang Y, Chai C
Int Urol Nephrol
. 2024 Dec;
57(4):1175-1187.
PMID: 39643860
Background: Environmental exposure to arsenic has long been associated with various clinical and pathophysiological aspects of urothelial carcinoma (UC), although the role of arsenic in UC and its impact on...
3.
Hsu Y, Luo C, Chang S, Lai C, Yang Y, Chen Y, et al.
Cancer Genomics Proteomics
. 2024 Aug;
21(5):523-532.
PMID: 39191496
Background/aim: Patients diagnosed with advanced metastatic colorectal cancer (CRC) confront a bleak prognosis characterized by low survival rates. Anoikis, the programmed apoptosis resistance exhibited by metastatic cancer cells, is a...
4.
Chang S, Chen W, Chai C
J Trace Elem Med Biol
. 2024 Aug;
86:127507.
PMID: 39137608
Inorganic arsenic (iAs)-induced urothelial carcinoma (UC) develops into a poor-prognosis malignancy. Arsenic-induced oxidative stress contributes to circadian rhythm disruption altered metabolism. Glutamine anaplerosis is a common metabolic feature of rapidly...
5.
Huang W, Hsu Y, Luo C, Chang S, Hung Y, Lai C, et al.
Life Sci
. 2024 Jul;
353:122914.
PMID: 39004275
Aims: Colorectal cancer (CRC) remains a major global health issue, with metastatic cases presenting poor prognosis despite advances in chemotherapy and targeted therapy. Irinotecan, a key drug for advanced CRC...
6.
Liu C, Chang S, Tsai M, Yang S
Appl Immunohistochem Mol Morphol
. 2023 Oct;
31(10):701-706.
PMID: 37807651
Introduction: Various cytologic specimens have been used to diagnose epidermal growth factor receptor (EGFR) gene mutations in non-small cell lung cancer (NSCLC). However, insufficient samples and lengthy DNA extraction procedures...
7.
Liu C, Chang S, Yang S, Tsai M, Tsai K
Int J Surg Pathol
. 2023 Aug;
32(4):679-683.
PMID: 37525545
The difficulty in diagnosis of severe melanocytic lesions is a problem to be overcome in pathological practice. Melanin bleaching is an effective approach to ameliorate melanin disturbances in severely pigmented...
8.
Wu C, Pan M, Shih S, Shiau J, Wu C, Chang S, et al.
Biomed Pharmacother
. 2023 May;
163:114732.
PMID: 37254289
Triple-negative breast cancer (TNBC) is characterized by the loss of expression of several biomarkers, which limits treatment strategies for the disease. In recent years, immunotherapy has shown promising results in...
9.
Chang S, Bin P, Luo C, Chai C
Pathol Res Pract
. 2022 Oct;
240:154173.
PMID: 36306724
Inorganic arsenic (iAs), a known human carcinogen, induces oxidative DNA damage and epigenetic silencing of tumor suppressor genes related to tumor progression. Chromodomain-helicase-DNA-binding protein 4 (CHD4) is a chromatin remodeling...
10.
Chang S, Chao C, Kwan A, Chai C
Pathol Oncol Res
. 2022 May;
28:1610230.
PMID: 35570844
CXCL13 may act as a mediator of tumor-associated macrophage immunity during malignant progression. The present study clarifies the clinicopathological significances of CXCL13 and its corresponding trend with M2 macrophage in...